Polito V

School of Psychological Sciences, Macquarie University, Sydney, NSW 2109, Australia.

7 papers · 1 preprint · ORCID

ArticlePsilocybin

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development.

Enriquez-Geppert S, Bevers L, Rosander A +2

Europe PMC2026
ArticlePsilocybin

Patient perspectives on research gaps in cluster headache.

Haghdoost F, Bahceci D, Delcourt C +15

Europe PMC2026
PreprintPsychedelics

Exploring flicker light mechanisms: No evidence that MEG signal diversity relates to subjective experience

Thurbon J, Sowman P, Polito V

Europe PMC2025
ArticlePsilocybin

Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.

Polito V, Liknaitzky P

Europe PMC2024
ArticlePsilocybin

A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.

Banushi B, Polito V

Europe PMC2023
ArticlePsilocybin

The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.

Polito V, Liknaitzky P

Europe PMC2022
ArticlePsilocybin

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Rootman JM, Kryskow P, Harvey K +6

Europe PMC2021
ArticlePsychedelics

A systematic study of microdosing psychedelics.

Polito V, Stevenson RJ

Europe PMC2019